169 related articles for article (PubMed ID: 9720096)
21. Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies.
Tanda N; Mori S; Saito K; Ikawa K; Sakamoto S
J Oral Pathol Med; 2000 Sep; 29(8):385-93. PubMed ID: 10972347
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
23. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
Smolewski P; Niewiadomska H; Los E; Robak T
Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas.
Chetty R; O'Leary JJ; Biddolph SC; Gatter KC
J Clin Pathol; 1995 Mar; 48(3):239-41. PubMed ID: 7730485
[TBL] [Abstract][Full Text] [Related]
26. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma].
Guan W; Yu S; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367
[TBL] [Abstract][Full Text] [Related]
27. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
[TBL] [Abstract][Full Text] [Related]
28. Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.
McPake CR; Tillman DM; Poquette CA; George EO; Houghton JA; Harris LC
Oncol Res; 1998; 10(5):235-44. PubMed ID: 9802058
[TBL] [Abstract][Full Text] [Related]
29. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
[TBL] [Abstract][Full Text] [Related]
30. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland.
Czyz W; Kuzdak K; Pasieka Z; Timler D; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():167-8. PubMed ID: 11820589
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783
[TBL] [Abstract][Full Text] [Related]
32. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
Jiwa NM; Oudejans JJ; Bai MC; Van den Brule AJ; Horstman A; Vos W; Van der Valk P; Kluin PM; Walboomers JM; Meijer CJ
Histopathology; 1995 Jun; 26(6):547-53. PubMed ID: 7665145
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease.
Chilosi M; Doglioni C; Menestrina F; Montagna L; Rigo A; Lestani M; Barbareschi M; Scarpa A; Mariuzzi GM; Pizzolo G
Blood; 1994 Dec; 84(12):4295-300. PubMed ID: 7994045
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
37. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas.
Camilleri-Broët S; Davi F; Feuillard J; Bourgeois C; Seilhean D; Hauw JJ; Raphaël M
Blood; 1995 Jul; 86(2):432-5. PubMed ID: 7605982
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
39. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD
J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835
[TBL] [Abstract][Full Text] [Related]
40. Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre).
Sandra F; Nakamura N; Mitsuyasu T; Shiratsuchi Y; Ohishi M
Histopathology; 2001 Jul; 39(1):93-8. PubMed ID: 11454049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
